Cargando…
MEDB-48. Infant medulloblastoma - SHH subtype – with residual disease. To treat or not to treat
Management of infant medulloblastoma remains a challenge. Front-line chemotherapy can successfully avoid radiation in low-risk infant medulloblastoma. Patients that do relapse can be salvaged long-term with radiotherapy. We report 4 cases of infants with medulloblastoma treated with chemotherapy (HI...
Autores principales: | Dahl, Christine, Depani, Sarita, Hedges, Kriti, Aguirregomezcorta, Fernando, Aquilina, Kristian, Jeelani, Owase, Carney, Olivia, Sudhakar, Sniya, Loebel, Ulrike, d′Árco, Felice, Mankad, Kshitij, Hargrave, Darren, Jorgensen, Mette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165101/ http://dx.doi.org/10.1093/neuonc/noac079.422 |
Ejemplares similares
-
MEDB-66. Investigating intra-tumoral heterogeneity of extrachromosomal DNA in SHH medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022) -
MEDB-49. Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?
por: Erker, Craig, et al.
Publicado: (2022) -
MEDB-22. iPSC-derived cerebellar organoid model for hereditary genetic predisposition in SHH-medulloblastoma
por: Manz, Frederik, et al.
Publicado: (2022) -
MEDB-54. Standard Risk Medulloblastoma treated solely with surgery and chemo-radiation
por: Cantor, Evan, et al.
Publicado: (2022) -
MEDB-15. Dynamic chromatin alteration induces oncogenic hijacking by essential transcriptional factors during SHH medulloblastoma tumorigenesis
por: Shiraishi, Ryo, et al.
Publicado: (2022)